{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:16:50Z","timestamp":1786634210177,"version":"build-2736575974"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s40257-025-00981-5","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T07:39:20Z","timestamp":1756712360000},"page":"863-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9130-9913","authenticated-orcid":false,"given":"Francis Li-Tien","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-1474","authenticated-orcid":false,"given":"Tsen-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"981_CR1","first-page":"33","volume":"13","author":"K Heidemeyer","year":"2023","unstructured":"Heidemeyer K, May Lee M, Cazzaniga S, Yawalkar N, Naldi L. Palmoplantar pustulosis: a systematic review of risk factors and therapies. Psoriasis (Auckl). 2023;13:33\u201358.","journal-title":"Psoriasis (Auckl)."},{"issue":"9","key":"981_CR2","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/jdv.18127","volume":"36","author":"F Assan","year":"2022","unstructured":"Assan F, Husson B, Hegazy S, Seneschal J, Aubin F, Mah\u00e9 E, et al. Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort. J Eur Acad Dermatol Venereol. 2022;36(9):1578\u201383.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"981_CR3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/1346-8138.15719","volume":"48","author":"N Serizawa","year":"2021","unstructured":"Serizawa N, Okazaki S, Otsuka Y, Koto M, Okabe K, Ito M, et al. Dietary habits in Japanese patients with palmoplantar pustulosis. J Dermatol. 2021;48(3):366\u201375.","journal-title":"J Dermatol"},{"issue":"2","key":"981_CR4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/bjd\/ljad134","volume":"189","author":"S Lofvendahl","year":"2023","unstructured":"Lofvendahl S, Norlin JM, Schmitt-Egenolf M. Comorbidities in palmoplantar pustulosis: a Swedish population-based register study. Br J Dermatol. 2023;189(2):230\u20132.","journal-title":"Br J Dermatol"},{"issue":"6","key":"981_CR5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamadermatol.2022.1081","volume":"158","author":"DH Kim","year":"2022","unstructured":"Kim DH, Lee JY, Cho SI, Jo SJ. Risks of comorbidities in patients with palmoplantar pustulosis vs patients with psoriasis vulgaris or pompholyx in Korea. JAMA Dermatol. 2022;158(6):650\u201360.","journal-title":"JAMA Dermatol"},{"issue":"11","key":"981_CR6","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1007\/s12325-023-02669-w","volume":"40","author":"D Ramcharran","year":"2023","unstructured":"Ramcharran D, Strober B, Gordon K, DeKlotz C, Fakharzadeh S, Yang YW, et al. The epidemiology of palmoplantar pustulosis: an analysis of multiple health insurance claims and electronic health records databases. Adv Ther. 2023;40(11):5090\u2013101.","journal-title":"Adv Ther"},{"key":"981_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1684\/ejd.2020.3702","volume":"30","author":"R M\u00f6ssner","year":"2020","unstructured":"M\u00f6ssner R, Pinter A. Paradoxical palmoplantar pustulosis induced by secukinumab and brodalumab: a report of three cases. Eur J Dermatol. 2020;30:177\u20138.","journal-title":"Eur J Dermatol"},{"issue":"6","key":"981_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.4951","volume":"47","author":"J Zhou","year":"2021","unstructured":"Zhou J, Luo Q, Cheng Y, Wen X, Liu J. An update on genetic basis of generalized pustular psoriasis (Review). Int J Mol Med. 2021;47(6):1\u201312.","journal-title":"Int J Mol Med"},{"issue":"1","key":"981_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000346572","volume":"226","author":"O Abbas","year":"2013","unstructured":"Abbas O, Itani S, Ghosn S, Kibbi AG, Fidawi G, Farooq M, et al. Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis. Dermatology. 2013;226(1):28\u201331.","journal-title":"Dermatology"},{"issue":"5","key":"981_CR10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/jid.2012.490","volume":"133","author":"N Setta-Kaffetzi","year":"2013","unstructured":"Setta-Kaffetzi N, Navarini AA, Patel VM, Pullabhatla V, Pink AE, Choon SE, et al. Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Invest Dermatol. 2013;133(5):1366\u20139.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"981_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/1346-8138.13551","volume":"44","author":"T Takahashi","year":"2017","unstructured":"Takahashi T, Fujimoto N, Kabuto M, Nakanishi T, Tanaka T. Mutation analysis of IL36RN gene in Japanese patients with palmoplantar pustulosis. J Dermatol. 2017;44(1):80\u20133.","journal-title":"J Dermatol"},{"issue":"6","key":"981_CR12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.abd.2019.01.008","volume":"94","author":"Y Xiaoling","year":"2019","unstructured":"Xiaoling Y, Dan S, Hongzhong J. Lack of association between mutation in IL36RN and palmoplantar pustular psoriasis in Chinese patients. An Bras Dermatol. 2019;94(6):658\u201363.","journal-title":"An Bras Dermatol"},{"issue":"1","key":"981_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00403-015-1611-x","volume":"308","author":"TS Wang","year":"2016","unstructured":"Wang TS, Chiu HY, Hong JB, Chan CC, Lin SJ, Tsai TF. Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients. Arch Dermatol Res. 2016;308(1):55\u201363.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"981_CR14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41423-020-0519-3","volume":"18","author":"R Uppala","year":"2021","unstructured":"Uppala R, Tsoi LC, Harms PW, Wang B, Billi AC, Maverakis E, et al. \u201cAutoinflammatory psoriasis\u201d\u2014genetics and biology of pustular psoriasis. Cell Mol Immunol. 2021;18(2):307\u201317.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"981_CR15","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/jid.2015.186","volume":"135","author":"R M\u00f6ssner","year":"2015","unstructured":"M\u00f6ssner R, Frambach Y, Wilsmann-Theis D, L\u00f6hr S, Jacobi A, Weyergraf A, et al. Palmoplantar pustular psoriasis is associated with missense variants in CARD14, but not with loss-of-function mutations in IL36RN in European patients. J Invest Dermatol. 2015;135(10):2538\u201341.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"981_CR16","first-page":"6","volume":"35","author":"FH Fu","year":"2019","unstructured":"Fu FH. Association of IL36RN mutation with palmoplantar pustulosis. China J Leprosy Skin Dis. 2019;35(1):6\u20138.","journal-title":"China J Leprosy Skin Dis"},{"key":"981_CR17","volume-title":"Variant analysis of IL36RN, CARD14, AP1S3 in Chinese Han population with palmoplantar pustulosis","author":"F Fu","year":"2019","unstructured":"Fu F. Variant analysis of IL36RN, CARD14, AP1S3 in Chinese Han population with palmoplantar pustulosis. Shandong: Shandong University; 2019."},{"issue":"8","key":"981_CR18","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/exd.14783","volume":"32","author":"CY Hsieh","year":"2023","unstructured":"Hsieh CY, Huang YW, Huang YH, Tsai TF. Deficiency of interleukin-36 receptor antagonist (DITRA): an analysis of 58 Chinese patients in a tertiary hospital in Taiwan. Exp Dermatol. 2023;32(8):1272\u20138.","journal-title":"Exp Dermatol"},{"issue":"12","key":"981_CR19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.1968.tb11947.x","volume":"80","author":"H Baker","year":"1968","unstructured":"Baker H, Ryan TJ. Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br J Dermatol. 1968;80(12):771\u201393.","journal-title":"Br J Dermatol"},{"issue":"3","key":"981_CR20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jid.2022.07.031","volume":"143","author":"A Niaouris","year":"2023","unstructured":"Niaouris A, Hernandez-Cordero A, Haddad S, Hassi NK, Benzian-Olsson N, Bugarin Diz C, et al. Damaging alleles affecting multiple CARD14 domains are associated with palmoplantar pustulosis. J Invest Dermatol. 2023;143(3):504\u20138.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"981_CR21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1684\/ejd.2018.3457","volume":"29","author":"F Fu","year":"2019","unstructured":"Fu F, Sun Y, Zhao Q, Yu G, Yang Q, Liu H, et al. Rare CARD14 missense variants associated with palmoplantar pustulosis (PPP) in the Chinese Han population. Eur J Dermatol. 2019;29(1):99\u2013100.","journal-title":"Eur J Dermatol"},{"issue":"7","key":"981_CR22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.humimm.2011.03.009","volume":"72","author":"K Douroudis","year":"2011","unstructured":"Douroudis K, Kingo K, Traks T, Ratsep R, Silm H, Vasar E, et al. ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis. Hum Immunol. 2011;72(7):613\u20135.","journal-title":"Hum Immunol"},{"issue":"3","key":"981_CR23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaci.2024.05.015","volume":"154","author":"A Hernandez-Cordero","year":"2024","unstructured":"Hernandez-Cordero A, Thomas L, Smail A, Lim ZQ, Saklatvala JR, Chung R, et al. A genome-wide meta-analysis of palmoplantar pustulosis implicates T(H)2 responses and cigarette smoking in disease pathogenesis. J Allergy Clin Immunol. 2024;154(3):657-65e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"981_CR24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2018.06.038","volume":"143","author":"S Twelves","year":"2019","unstructured":"Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, et al. Clinical and genetic differences between pustular psoriasis subtypes. J Allergy Clin Immunol. 2019;143(3):1021\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"981_CR25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2133.1978.tb02013.x","volume":"99","author":"JM Ward","year":"1978","unstructured":"Ward JM, Barnes RMR. HLA antigens in persistent palmoplantar pustulosis and its relationship to psoriasis. Br J Dermatol. 1978;99(5):477\u201383.","journal-title":"Br J Dermatol"},{"issue":"4","key":"981_CR26","first-page":"262","volume":"25","author":"Y Xiao","year":"1992","unstructured":"Xiao Y, Song FJ, Li HG, et al. A study on the correlation between HLA antigens and palmoplantar pustulosis. Chin J Dermatol. 1992;25(4):262\u20133.","journal-title":"Chin J Dermatol"},{"issue":"4","key":"981_CR27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000247168","volume":"188","author":"H Torii","year":"2009","unstructured":"Torii H, Nakagawa H, Ishibashi Y, Tokunaga K, Juji T. Genetic polymorphisms in HLA-A, -B, -C and -DR antigens in Japanese patients with palmoplantar pustulosis. Dermatology. 2009;188(4):290\u20132.","journal-title":"Dermatology"},{"issue":"2","key":"981_CR28","first-page":"109","volume":"2","author":"GX Fu Hongjun","year":"2009","unstructured":"Fu Hongjun GX, Xiaofeng D, Furen Z. A study on the association between palmoplantar pustulosis, impetigo herpetiformis, and the HLA-DQB1 allele. China J Leprosy Skin Dis. 2009;2(2):109\u201310.","journal-title":"China J Leprosy Skin Dis"},{"issue":"5","key":"981_CR29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/bjd.17832","volume":"181","author":"YMF Andersen","year":"2019","unstructured":"Andersen YMF, Augustin M, Petersen J, Hagenstrom K, Mallbris L, Burge R, et al. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis. Br J Dermatol. 2019;181(5):976\u201382.","journal-title":"Br J Dermatol"},{"issue":"5","key":"981_CR30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/bjd.20087","volume":"185","author":"S Lofvendahl","year":"2021","unstructured":"Lofvendahl S, Norlin JM, Schmitt-Egenolf M. Prevalence and incidence of palmoplantar pustulosis in Sweden: a population-based register study. Br J Dermatol. 2021;185(5):945\u201351.","journal-title":"Br J Dermatol"},{"key":"981_CR31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2133.1964.tb14502.x","volume":"76","author":"PJ Ashurst","year":"1964","unstructured":"Ashurst PJ. Relapsing pustular eruptions of the hands and feet. Br J Dermatol. 1964;76:169\u201380.","journal-title":"Br J Dermatol"},{"issue":"7","key":"981_CR32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.1957.tb13266.x","volume":"69","author":"J Everall","year":"1957","unstructured":"Everall J. Intractable pustular eruptions of the hands and feet; a review of 70 patients. Br J Dermatol. 1957;69(7):269\u201372.","journal-title":"Br J Dermatol"},{"issue":"4","key":"981_CR33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2340\/0001555551289294","volume":"51","author":"W Enfors","year":"1971","unstructured":"Enfors W, Molin L. Pustulosis palmaris et plantaris. A follow-up study of a ten-year material. Acta Derm Venereol. 1971;51(4):289\u201394.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"981_CR34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2340\/0001555551284288","volume":"51","author":"L Hellgren","year":"1971","unstructured":"Hellgren L, Mobacken H. Pustulosis palmaris et plantaris. Prevalence, clinical observations and prognosis. Acta Derm Venereol. 1971;51(4):284\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"981_CR35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-2133.1996.tb07946.x","volume":"134","author":"AD Burden","year":"1996","unstructured":"Burden AD, Kemmett D. The spectrum of nail involvement in palmoplantar pustulosis. Br J Dermatol. 1996;134(6):1079\u201382.","journal-title":"Br J Dermatol"},{"issue":"3","key":"981_CR36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2133.1998.02113.x","volume":"138","author":"M-O Eriksson","year":"1998","unstructured":"Eriksson M-O, Hagforsen E, Lundin IP, Micha\u00cblsson G. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol. 1998;138(3):390\u20138.","journal-title":"Br J Dermatol"},{"issue":"5","key":"981_CR37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/000155502320624069","volume":"82","author":"E Hagforsen","year":"2002","unstructured":"Hagforsen E, Awder M, Lefvert AK, Nordlind K, Michaelsson G. Palmoplantar pustulosis: an autoimmune disease precipitated by smoking? Acta Derm Venereol. 2002;82(5):341\u20136.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"981_CR38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1747.2003.12094.x","volume":"120","author":"K Asumalahti","year":"2003","unstructured":"Asumalahti K, Ameen M, Suomela S, Hagforsen E, Michaelsson G, Evans J, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol. 2003;120(4):627\u201332.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"981_CR39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1468-3083.2003.00510.x","volume":"17","author":"R Gim\u00e9nez-Garc\u00eda","year":"2003","unstructured":"Gim\u00e9nez-Garc\u00eda R, S\u00e1nchez-Ram\u00f3n S, Cuellar-Olmedo LA. Palmoplantar pustulosis: a clinicoepidemiological study. The relationship between tobacco use and thyroid function. J Eur Acad Dermatol Venereol. 2003;17(3):276\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"981_CR40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2133.2006.07725.x","volume":"156","author":"G Micha\u00eblsson","year":"2007","unstructured":"Micha\u00eblsson G, Kristjansson G, Lundin I, Hagforsen E. Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet. Br J Dermatol. 2007;156:659\u201366.","journal-title":"Br J Dermatol"},{"issue":"10","key":"981_CR41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1468-3083.2009.03282.x","volume":"23","author":"HA Miot","year":"2009","unstructured":"Miot HA, Miot LDB, Lopes PS, Haddad GR, Marques SA. Association between palmoplantar pustulosis and cigarette smoking in Brazil: a case\u2013control study. J Eur Acad Dermatol Venereol. 2009;23(10):1173\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"981_CR42","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10081171","volume":"10","author":"P Gisondi","year":"2022","unstructured":"Gisondi P, Bellinato F, Girolomoni G. Clinical characteristics of patients with pustular psoriasis: a single-center retrospective observational study. Vaccines. 2022;10(8): 1171.","journal-title":"Vaccines"},{"issue":"3","key":"981_CR43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s13555-024-01109-z","volume":"14","author":"A Cheng","year":"2024","unstructured":"Cheng A, Deng X, Yang F, Liu C, Neasham D, Kilcoyne T, et al. Treatment patterns and negative health outcomes in palmoplantar pustulosis patients in Germany and the US. Dermatol Ther (Heidelb). 2024;14(3):627\u201341.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"981_CR44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1468-3083.2010.03648.x","volume":"24","author":"A Brunasso","year":"2010","unstructured":"Brunasso A, Massone C. Can we really separate palmoplantar pustulosis from psoriasis? J Eur Acad Dermatol Venereol. 2010;24:619\u201321.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"981_CR45","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/bjd.12223","volume":"168","author":"AM Brunasso","year":"2013","unstructured":"Brunasso AM, Puntoni M, Aberer W, Delfino C, Fancelli L, Massone C. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study. Br J Dermatol. 2013;168(6):1243\u201351.","journal-title":"Br J Dermatol"},{"issue":"10","key":"981_CR46","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/jdv.14187","volume":"31","author":"H Trattner","year":"2017","unstructured":"Trattner H, Bluml S, Steiner I, Plut U, Radakovic S, Tanew A. Quality of life and comorbidities in palmoplantar pustulosis \u2013 a cross-sectional study on 102 patients. J Eur Acad Dermatol Venereol. 2017;31(10):1681\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"981_CR47","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.mayocp.2017.05.029","volume":"92","author":"JM Olazagasti","year":"2017","unstructured":"Olazagasti JM, Ma JE, Wetter DA. Clinical features, etiologic factors, associated disorders, and treatment of palmoplantar pustulosis: the Mayo Clinic experience, 1996\u20132013. Mayo Clin Proc. 2017;92(9):1351\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"981_CR48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/24755303221146990","volume":"8","author":"MG Lebwohl","year":"2022","unstructured":"Lebwohl MG, Medeiros RA, Mackey RH, Valdecantos WC, Brodovicz KG, Lertratanakul A, et al. Palmoplantar pustulosis has a greater disease burden than plaque psoriasis: real-world evidence from the CorEvitas Psoriasis Registry. J Psoriasis Psoriatic Arthritis. 2022;8(2):56\u201365.","journal-title":"J Psoriasis Psoriatic Arthritis"},{"issue":"11","key":"981_CR49","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jamadermatol.2020.3275","volume":"156","author":"N Benzian-Olsson","year":"2020","unstructured":"Benzian-Olsson N, Dand N, Chaloner C, Bata-Csorgo Z, Borroni R, Burden AD, et al. Association of clinical and demographic factors with the severity of palmoplantar pustulosis. JAMA Dermatol. 2020;156(11):1216\u201322.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"981_CR50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaad.2023.08.110","volume":"90","author":"O Kam","year":"2024","unstructured":"Kam O, George SE, Osborne S, Smith B, Thacker S, Vo C, et al. Prevalence of palmoplantar pustulosis in the United States using the all of Us research database. J Am Acad Dermatol. 2024;90(2):403\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"981_CR51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamadermatol.2021.4635","volume":"158","author":"MH Noe","year":"2022","unstructured":"Noe MH, Wan MT, Mostaghimi A, Gelfand JM, Pustular Psoriasis in the USRG, Agnihothri R, et al. Evaluation of a case series of patients with palmoplantar pustulosis in the United States. JAMA Dermatol. 2022;158(1):68\u201372.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"981_CR52","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.5070\/D3234034627","volume":"23","author":"D Wilsmann-Theis","year":"2017","unstructured":"Wilsmann-Theis D, Jacobi A, Frambach Y, Philipp S, Weyergraf A, Schill T, et al. Palmoplantar pustulosis\u2014a cross-sectional analysis in Germany. Dermatol Online J. 2017;23(4):13030.","journal-title":"Dermatol Online J"},{"issue":"4","key":"981_CR53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/bjd\/ljae217","volume":"191","author":"M Frysz","year":"2024","unstructured":"Frysz M, Patel S, Li MOY, Griffiths CEM, Warren RB, Ashcroft DM. Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study. Br J Dermatol. 2024;191(4):529\u201338.","journal-title":"Br J Dermatol"},{"issue":"2","key":"981_CR54","first-page":"109","volume":"26","author":"M Misiak-Galazka","year":"2018","unstructured":"Misiak-Galazka M, Wolska H, Galazka A, Kwiek B, Rudnicka L. General characteristics and comorbidities in patients with palmoplantar pustulosis. Acta Dermatovenerol Croat. 2018;26(2):109\u201318.","journal-title":"Acta Dermatovenerol Croat"},{"issue":"6","key":"981_CR55","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0190-9622(88)70265-0","volume":"19","author":"K Rosen","year":"1988","unstructured":"Rosen K, Lindstedt G, Mobacken H, Nystrom E. Thyroid function in patients with pustulosis palmoplantaris. J Am Acad Dermatol. 1988;19(6):1009\u201316.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"981_CR56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006450","volume":"5","author":"K Kubota","year":"2015","unstructured":"Kubota K, Kamijima Y, Sato T, Ooba N, Koide D, Iizuka H, et al. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ Open. 2015;5(1): e006450.","journal-title":"BMJ Open"},{"issue":"6","key":"981_CR57","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5021\/ad.2017.29.6.761","volume":"29","author":"JY Lee","year":"2017","unstructured":"Lee JY, Kang S, Park JS, Jo SJ. Prevalence of psoriasis in Korea: a population-based epidemiological study using the Korean National Health Insurance Database. Ann Dermatol. 2017;29(6):761\u20137.","journal-title":"Ann Dermatol"},{"issue":"7","key":"981_CR58","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-3083.2009.03197.x","volume":"23","author":"E Adisen","year":"2009","unstructured":"Adisen E, Tekin O, Gulekon A, Gurer MA. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Acad Dermatol Venereol. 2009;23(7):814\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"981_CR59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.abd.2019.04.008","volume":"95","author":"A Oktem","year":"2020","unstructured":"Oktem A, Uysal PI, Akdogan N, Tokmak A, Yalcin B. Clinical characteristics and associations of palmoplantar pustulosis: an observational study. An Bras Dermatol. 2020;95(1):15\u20139.","journal-title":"An Bras Dermatol"},{"issue":"9","key":"981_CR60","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/1346-8138.15470","volume":"47","author":"CM Huang","year":"2020","unstructured":"Huang CM, Tsai TF. Clinical characteristics, genetics, comorbidities and treatment of palmoplantar pustulosis: a retrospective analysis of 66 cases in a single center in Taiwan. J Dermatol. 2020;47(9):1046\u20139.","journal-title":"J Dermatol"},{"issue":"3","key":"981_CR61","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/1346-8138.15716","volume":"48","author":"M Kim","year":"2021","unstructured":"Kim M, Yang S, Kim BR, Youn SW. Nail involvement features in palmoplantar pustulosis. J Dermatol. 2021;48(3):360\u20135.","journal-title":"J Dermatol"},{"issue":"6","key":"981_CR62","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40257-023-00807-2","volume":"24","author":"H-M Wang","year":"2023","unstructured":"Wang H-M, Xu J-M, Jin H-Z. Characteristics and burdens of disease in patients from Beijing with generalized pustular psoriasis and palmoplantar pustulosis: multicenter retrospective cohort study using a regional database. Am J Clin Dermatol. 2023;24(6):991\u20131002.","journal-title":"Am J Clin Dermatol"},{"key":"981_CR63","unstructured":"Liu KYKL. Treatment of 45 cases of palmoplantar pustulosis with acitretin. Chin J Dermatol. 2006;39(11):677."},{"issue":"3","key":"981_CR64","first-page":"180","volume":"39","author":"SKLP Chen","year":"2006","unstructured":"Chen SKLP, Lee Y, Zhang ML. Treatment of 50 cases of palmoplantar pustulosis with acitretin. Chin J Dermatol. 2006;39(3):180.","journal-title":"Chin J Dermatol"},{"issue":"2","key":"981_CR65","first-page":"117","volume":"31","author":"YL Wang","year":"1998","unstructured":"Wang YL, Wang YZ, Jiang H, Wang ZM. Analysis of pathogenic factors in 347 cases of palmoplantar pustulosis. Chin J Dermatol. 1998;31(2):117.","journal-title":"Chin J Dermatol"},{"issue":"7","key":"981_CR66","doi-asserted-by":"crossref","DOI":"10.1007\/s00403-024-03188-6","volume":"316","author":"F Meng","year":"2024","unstructured":"Meng F, Zhang C, Wang Y, Shang Y, Yimingjiang M, Lin Z, et al. Assessment of sexual function in patients with palmoplantar pustulosis: a cross-sectional study. Arch Dermatol Res. 2024;316(7): 465.","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"981_CR67","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/1346-8138.16164","volume":"48","author":"T Tosukhowong","year":"2021","unstructured":"Tosukhowong T, Kiratikanon S, Wonglamsam P, Netiviwat J, Innu T, Rujiwetpongstorn R, et al. Epidemiology and clinical features of pustular psoriasis: a 15-year retrospective cohort. J Dermatol. 2021;48(12):1931\u20135.","journal-title":"J Dermatol"},{"issue":"6","key":"981_CR68","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/1346-8138.13751","volume":"44","author":"M Kouno","year":"2017","unstructured":"Kouno M, Nishiyama A, Minabe M, Iguchi N, Ukichi K, Nomura T, et al. Retrospective analysis of the clinical response of palmoplantar pustulosis after dental infection control and dental metal removal. J Dermatol. 2017;44(6):695\u20138.","journal-title":"J Dermatol"},{"issue":"6","key":"981_CR69","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jid.2020.09.028","volume":"141","author":"K Kobayashi","year":"2021","unstructured":"Kobayashi K, Kamekura R, Kato J, Kamiya S, Kamiya T, Takano K, et al. Cigarette smoke underlies the pathogenesis of palmoplantar pustulosis via an IL-17A-induced production of IL-36gamma in tonsillar epithelial cells. J Invest Dermatol. 2021;141(6):1533\u201341.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"981_CR70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232738","volume":"15","author":"C Miyazaki","year":"2020","unstructured":"Miyazaki C, Sruamsiri R, Mahlich J, Jung W. Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: a claims database study. PLoS ONE. 2020;15(5): e0232738.","journal-title":"PLoS ONE"},{"issue":"4","key":"981_CR71","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1111\/jdv.15434","volume":"33","author":"Y Masui","year":"2019","unstructured":"Masui Y, Ito A, Akiba Y, Uoshima K, Abe R. Dental metal allergy is not the main cause of palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2019;33(4):e180.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"981_CR72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdermsci.2020.03.003","volume":"98","author":"M Murakami","year":"2020","unstructured":"Murakami M, Terui T. Palmoplantar pustulosis: current understanding of disease definition and pathomechanism. J Dermatol Sci. 2020;98(1):13\u20139.","journal-title":"J Dermatol Sci"},{"issue":"6","key":"981_CR73","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archderm.1935.01470060002001","volume":"32","author":"GC Andrews","year":"1935","unstructured":"Andrews GC, Machacek GF. Pustular bacterids of the hands and feet. Arch Derm Syphilol. 1935;32(6):837\u201347.","journal-title":"Arch Derm Syphilol"},{"issue":"5","key":"981_CR74","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s40257-023-00788-2","volume":"24","author":"T Terui","year":"2023","unstructured":"Terui T, Okubo Y, Kobayashi S, Sano S, Morita A, Imafuku S, et al. Efficacy and safety of apremilast for the treatment of Japanese patients with palmoplantar pustulosis: results from a phase 2, randomized, placebo-controlled study. Am J Clin Dermatol. 2023;24(5):837\u201347.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"981_CR75","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-0536.1998.tb05857.x","volume":"39","author":"JA Yiannias","year":"1998","unstructured":"Yiannias JA, Winkelmann RK, Connolly SM. Contact sensitivities in palmar plantar pustulosis (acropustulosis). Contact Dermatitis. 1998;39(3):108\u201311.","journal-title":"Contact Dermatitis"},{"issue":"2","key":"981_CR76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5826\/dpc.0902a05","volume":"9","author":"AMG Brunasso Vernetti","year":"2019","unstructured":"Brunasso Vernetti AMG, Puntoni M, Massone C. Palmoplantar pustulosis and allergies: a systematic review. Dermatol Pract Concept. 2019;9(2):105\u201310.","journal-title":"Dermatol Pract Concept"},{"issue":"11","key":"981_CR77","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/1346-8138.12272","volume":"40","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T. Pustulotic arthro-osteitis associated with palmoplantar pustulosis. J Dermatol. 2013;40(11):857\u201363.","journal-title":"J Dermatol"},{"issue":"4","key":"981_CR78","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ijd.14788","volume":"59","author":"T Yamamoto","year":"2020","unstructured":"Yamamoto T, Hiraiwa T, Tobita R, Hirano H, Masuda-Kuroki K, Ishii M, et al. Characteristics of Japanese patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis: a multicenter study. Int J Dermatol. 2020;59(4):441\u20134.","journal-title":"Int J Dermatol"},{"issue":"10","key":"981_CR79","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/jdv.16355","volume":"34","author":"T Yamamoto","year":"2020","unstructured":"Yamamoto T, Fukuda K, Morita A, Kimura T, Morishima H, Goto R, et al. Efficacy of guselkumab in a subpopulation with pustulotic arthro-osteitis through week 52: an exploratory analysis of a phase 3, randomized, double-blind, placebo-controlled study in Japanese patients with palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2020;34(10):2318\u201329.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"981_CR80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40261-018-00745-6","volume":"39","author":"T Yamamoto","year":"2019","unstructured":"Yamamoto T. Clinical characteristics of Japanese patients with palmoplantar pustulosis. Clin Drug Investig. 2019;39(3):241\u201352.","journal-title":"Clin Drug Investig"},{"key":"981_CR81","unstructured":"Zhu HLH, CM, Lo Q, Lin, L, Zhang XB. Treatment of 68 cases of palmoplantar pustulosis with acitretin. Chin J Dermatol. 2005;38(10):653."},{"issue":"7","key":"981_CR82","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archderm.1982.01650190012009","volume":"118","author":"M Takigawa","year":"1982","unstructured":"Takigawa M, Miyachi Y, Uehara M, Tagami H. Treatment of pustulosis palmaris et plantaris with oral doses of colchicine. Arch Dermatol. 1982;118(7):458\u201360.","journal-title":"Arch Dermatol"},{"issue":"3","key":"981_CR83","first-page":"216","volume":"68","author":"SS Wong","year":"2001","unstructured":"Wong SS, Tan KC, Goh CL. Long-term colchicine for recalcitrant palmoplantar pustulosis: treatment outcome in 3 patients. Cutis. 2001;68(3):216\u20138.","journal-title":"Cutis"},{"issue":"5","key":"981_CR84","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/1744666X.2023.2185775","volume":"19","author":"J-M Xu","year":"2023","unstructured":"Xu J-M, Wang H-M, Jin H-Z. An update on therapeutic options for palmoplantar pustulosis: a narrative review and expert recommendations. Expert Rev Clin Immunol. 2023;19(5):499\u2013516.","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"981_CR85","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2133.1973.tb02977.x","volume":"89","author":"K Thomsen","year":"1973","unstructured":"Thomsen K, \u00d8Sterbye P. Pustulosis palmaris et plantaris. Br J Dermatol. 1973;89(3):293\u20136.","journal-title":"Br J Dermatol"},{"issue":"3","key":"981_CR86","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2133.1976.tb07020.x","volume":"95","author":"JM Ward","year":"1976","unstructured":"Ward JM, Corbett MF, Hanna MJ. A double-blind trial of clomocycline in the treatment of persistent palmoplantar pustulosis. Br J Dermatol. 1976;95(3):317\u201322.","journal-title":"Br J Dermatol"},{"key":"981_CR87","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Gu M, Zheng Z, Jiang H, Han L, Huang H, et al. Therapeutic approaches for SAPHO syndrome from the perspective of pathogenesis: a review of the literature. Front Immunol. 2025;16: 1560398.","journal-title":"Front Immunol"},{"issue":"11","key":"981_CR88","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/1346-8138.16855","volume":"50","author":"H Terui","year":"2023","unstructured":"Terui H, Segawa Y, Otake E, Omori R, Tsuchiyama K, Kikuchi K, et al. Successful treatment of pustulotic arthro-osteitis with amoxicillin: a case report and review of the literature. J Dermatol. 2023;50(11):1478\u201383.","journal-title":"J Dermatol"},{"issue":"4","key":"981_CR89","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14041366","volume":"14","author":"M Ferraioli","year":"2025","unstructured":"Ferraioli M, Levani J, De Luca R, Matucci-Cerinic C, Gattorno M, Guiducci S, et al. What is new and what is next for SAPHO syndrome management: a narrative review. J Clin Med. 2025;14(4): 1366.","journal-title":"J Clin Med"},{"issue":"7","key":"981_CR90","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1346-8138.14348","volume":"45","author":"M Takahara","year":"2018","unstructured":"Takahara M, Hirata Y, Nagato T, Kishibe K, Katada A, Hayashi T, et al. Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: a retrospective subjective and objective quantitative analysis of 138 patients. J Dermatol. 2018;45(7):812\u201323.","journal-title":"J Dermatol"},{"key":"981_CR91","first-page":"86","volume":"72","author":"M Takahara","year":"2011","unstructured":"Takahara M. Clinical outcome of tonsillectomy for palmoplantar pustulosis and etiological relationship between palmoplantar pustulosis and tonsils. Adv Otorhinolaryngol. 2011;72:86\u20138.","journal-title":"Adv Otorhinolaryngol"},{"issue":"3","key":"981_CR92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S0027763000019425","volume":"26","author":"H Ito","year":"1981","unstructured":"Ito H, Suzuki Y. Effect of tonsillectomy on palmoplantar pustulosis in tonsillar focal infection. Nagoya Med J. 1981;26(3):53\u201361.","journal-title":"Nagoya Med J"},{"issue":"4","key":"981_CR93","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.anl.2024.05.010","volume":"51","author":"M Takahara","year":"2024","unstructured":"Takahara M, Doi A, Inoshita A, Ohori J, Kono M, Hirano A, et al. Guidance of clinical management for patients with tonsillar focal disease. Auris Nasus Larynx. 2024;51(4):761\u201373.","journal-title":"Auris Nasus Larynx"},{"issue":"4","key":"981_CR94","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/1346-8138.17667","volume":"52","author":"N Abe","year":"2025","unstructured":"Abe N, Higashi Y, Tateishi C, Kanekura T, Tsuruta D, Kobayashi T, et al. Efficacy of granulocyte and monocyte adsorptive apheresis on skin and joint manifestations of palmoplantar pustulosis with pustulotic arthro-osteitis: a multicentric, prospective, observational study. J Dermatol. 2025;52(4):642\u201350.","journal-title":"J Dermatol"},{"issue":"8","key":"981_CR95","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/ijd.13608","volume":"56","author":"S Hayashi","year":"2017","unstructured":"Hayashi S, Shimaoka Y, Hamasaki Y, Hatamochi A. Palmoplantar pustulosis and pustulotic arthro-osteitis treatment with potassium iodide and tetracycline, a novel remedy with an old drug: a review of 25 patients. Int J Dermatol. 2017;56(8):889\u201393.","journal-title":"Int J Dermatol"},{"issue":"5","key":"981_CR96","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jaad.2024.06.071","volume":"91","author":"YC Tsai","year":"2024","unstructured":"Tsai YC, Hsu FL, Tsai TF. Targeted immunotherapy for moderate-to-severe palmoplantar pustulosis: a network meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2024;91(5):955\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"981_CR97","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/1346-8138.17659","volume":"52","author":"Y Okubo","year":"2025","unstructured":"Okubo Y, Murakami M, Kobayashi S, Tsuji S, Kishimoto M, Ikeda K, et al. Risankizumab in Japanese patients with moderate-to-severe palmoplantar pustulosis: results from the randomized, phase 3 JumPPP study. J Dermatol. 2025;52(4):593\u2013602.","journal-title":"J Dermatol"},{"issue":"5","key":"981_CR98","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s40257-024-00876-x","volume":"25","author":"Y Okubo","year":"2024","unstructured":"Okubo Y, Kobayashi S, Murakami M, Sano S, Kikuta N, Ouchi Y, et al. Efficacy and safety of brodalumab, an anti-interleukin-17 receptor A monoclonal antibody, for palmoplantar pustulosis: 16-week results of a randomized clinical trial. Am J Clin Dermatol. 2024;25(5):837\u201347.","journal-title":"Am J Clin Dermatol"},{"key":"981_CR99","unstructured":"Reich A, Gudjonsson JRA, Barker J, Pink A, Reynolds N, Griffiths C. Imsidolimab, an anti-IL-36 receptor monoclonal antibody, in the treatment of generalized pustular psoriasis: results from a phase 2 trial. In: 30th EADV Congress; 2021: 29."},{"issue":"10","key":"981_CR100","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s13555-023-01002-1","volume":"13","author":"AD Burden","year":"2023","unstructured":"Burden AD, Bissonnette R, Navarini AA, Murakami M, Morita A, Haeufel T, et al. Spesolimab efficacy and safety in patients with moderate-to-severe palmoplantar pustulosis: a multicentre, double-blind, randomised, placebo-controlled, phase IIb, dose-finding study. Dermatol Ther (Heidelb). 2023;13(10):2279\u201397.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"5","key":"981_CR101","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaad.2019.01.066","volume":"80","author":"U Mrowietz","year":"2019","unstructured":"Mrowietz U, Bachelez H, Burden AD, Rissler M, Sieder C, Orsenigo R, et al. Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: results of the 2PRECISE study. J Am Acad Dermatol. 2019;80(5):1344\u201352.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"981_CR102","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/jdv.17441","volume":"35","author":"D Wilsmann-Theis","year":"2021","unstructured":"Wilsmann-Theis D, Kromer C, Gerdes S, Linker C, Magnolo N, Sabat R, et al. A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS). J Eur Acad Dermatol Venereol. 2021;35(10):2045\u201350.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"981_CR103","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jamadermatol.2019.1394","volume":"155","author":"T Terui","year":"2019","unstructured":"Terui T, Kobayashi S, Okubo Y, Murakami M, Zheng R, Morishima H, et al. Efficacy and safety of guselkumab in Japanese patients with palmoplantar pustulosis: a phase 3 randomized clinical trial. JAMA Dermatol. 2019;155(10):1153\u201361.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"981_CR104","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamadermatol.2017.5937","volume":"154","author":"T Terui","year":"2018","unstructured":"Terui T, Kobayashi S, Okubo Y, Murakami M, Hirose K, Kubo H. Efficacy and safety of guselkumab, an anti-interleukin 23 monoclonal antibody, for palmoplantar pustulosis: a randomized clinical trial. JAMA Dermatol. 2018;154(3):309\u201316.","journal-title":"JAMA Dermatol"},{"key":"981_CR105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jdin.2024.09.001","volume":"18","author":"D Wilsmann-Theis","year":"2025","unstructured":"Wilsmann-Theis D, Patt S, Pinter A, Gerdes S, Magnolo N, Nemeth R, et al. Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: a multi-center, single-arm clinical trial (GAP study). JAAD Int. 2025;18:69\u201378.","journal-title":"JAAD Int"},{"issue":"2","key":"981_CR106","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13555-021-00504-0","volume":"11","author":"U Mrowietz","year":"2021","unstructured":"Mrowietz U, Burden AD, Pinter A, Reich K, Schakel K, Baum P, et al. Spesolimab, an anti-interleukin-36 receptor antibody, in patients with palmoplantar pustulosis: results of a phase IIa, multicenter, double-blind, randomized, placebo-controlled pilot study. Dermatol Ther (Heidelb). 2021;11(2):571\u201385.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"2","key":"981_CR107","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jaad.2020.06.038","volume":"84","author":"U Mrowietz","year":"2021","unstructured":"Mrowietz U, Bachelez H, Burden AD, Rissler M, Sieder C, Orsenigo R, et al. Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: extension of the 2PRECISE study. J Am Acad Dermatol. 2021;84(2):552\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"981_CR108","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15079","volume":"34","author":"C Peng","year":"2021","unstructured":"Peng C, Hu Y, Chen W, Ding Y, Li X, Yu N, et al. A randomized prospective study of different dose regimens using the 308-nm excimer laser in the treatment of palmoplantar pustulosis. Dermatol Ther. 2021;34(5): e15079.","journal-title":"Dermatol Ther"},{"key":"981_CR109","volume":"253","author":"R Xia","year":"2023","unstructured":"Xia R, Liu J, Gao Y, Diao Z, Chen D, Zhou C, et al. Local injection of micro-dose anti-interleukin-17A antibody for palmoplantar pustulosis: a real-world study. Clin Immunol. 2023;253: 109694.","journal-title":"Clin Immunol"},{"issue":"1","key":"981_CR110","doi-asserted-by":"crossref","first-page":"8829762","DOI":"10.1155\/2024\/8829762","volume":"2024","author":"G Wang","year":"2024","unstructured":"Wang G, Zhang S, Yan H, Qi F, Zhang B, Li Y, et al. Efficacy and safety of benvitimod in patients with palmoplantar pustulosis: an open-label, multicenter, prospective study. Dermatol Ther. 2024;2024(1):8829762.","journal-title":"Dermatol Ther"},{"key":"981_CR111","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2023.103829","volume":"44","author":"J Huang","year":"2023","unstructured":"Huang J, Wu M, Wang H. Photodynamic therapy for palmoplantar pustulosis: a case report. Photodiagnosis Photodyn Ther. 2023;44: 103829.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"6","key":"981_CR112","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s13555-025-01419-w","volume":"15","author":"Y-Y Sung","year":"2025","unstructured":"Sung Y-Y, Tsai T-F. Topical crisaborole for the treatment of recalcitrant palmoplantar pustulosis: a case series. Dermatol Ther (Heidelb). 2025;15(6):1579\u201385.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"3","key":"981_CR113","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1346-8138.13064","volume":"43","author":"Y Umezawa","year":"2016","unstructured":"Umezawa Y, Nakagawa H, Tamaki K. Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: a randomized, double-blind, placebo-controlled trial. J Dermatol. 2016;43(3):288\u201393.","journal-title":"J Dermatol"},{"issue":"6","key":"981_CR114","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00403-010-1112-x","volume":"303","author":"K Torii","year":"2011","unstructured":"Torii K, Furuhashi T, Saito C, Kato H, Nishioka A, Nishida E, et al. Increased peripheral Th17 in patients with pustulosis palmaris et plantaris. Arch Dermatol Res. 2011;303(6):441\u20134.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"981_CR115","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2022.04.027","volume":"150","author":"D McCluskey","year":"2022","unstructured":"McCluskey D, Benzian-Olsson N, Mahil SK, Hassi NK, Wohnhaas CT, Apricot, et al. Single-cell analysis implicates T(H)17-to-T(H)2 cell plasticity in the pathogenesis of palmoplantar pustulosis. J Allergy Clin Immunol. 2022;150(4):882\u201393.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"981_CR116","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1600-0625.2011.01325.x","volume":"20","author":"M Murakami","year":"2011","unstructured":"Murakami M, Hagforsen E, Morhenn V, Ishida-Yamamoto A, Iizuka H. Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum. Exp Dermatol. 2011;20(10):845\u20137.","journal-title":"Exp Dermatol"},{"issue":"4","key":"981_CR117","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/bjd\/ljac130","volume":"188","author":"D Gleeson","year":"2023","unstructured":"Gleeson D, Barker J, Capon F, Pink AE, Woolf RT, Smith CH, et al. Are janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic. Br J Dermatol. 2023;188(4):471\u20133.","journal-title":"Br J Dermatol"},{"issue":"4","key":"981_CR118","doi-asserted-by":"crossref","first-page":"540","DOI":"10.25259\/IJDVL_751_2024","volume":"91","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Zhang X, Wang H, Yang R, Luo S. Clinical efficacy and safety of upadacitinib in the treatment of palmoplantar pustulosis: a single-center retrospective study. Indian J Dermatol Venereol Leprol. 2025;91(4):540\u20133.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"981_CR119","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.2147\/IDR.S421299","volume":"16","author":"Q Xu","year":"2023","unstructured":"Xu Q, Wang X, Yang A, Wei G. Refractory palmoplantar pustulosis successfully treated with JAK inhibitor tofacitinib: a case series. Infect Drug Resist. 2023;16:5165\u201372.","journal-title":"Infect Drug Resist"},{"key":"981_CR120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jdcr.2023.02.017","volume":"35","author":"HD Smith","year":"2023","unstructured":"Smith HD, Montoya L, De Benedetto A. Recalcitrant palmoplantar pustulosis controlled with dupilumab. JAAD Case Rep. 2023;35:33\u20137.","journal-title":"JAAD Case Rep"},{"issue":"5","key":"981_CR121","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/all.16019","volume":"79","author":"YX Zheng","year":"2024","unstructured":"Zheng YX, Chen XB, Wang ZY, Cai SQ, Zheng M, Koh LF, et al. Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation. Allergy. 2024;79(5):1361\u20134.","journal-title":"Allergy"},{"issue":"7","key":"981_CR122","first-page":"13030","volume":"24","author":"D Yan","year":"2018","unstructured":"Yan D, Afifi L, Jeon C, Cordoro KM, Liao W. A cross-sectional study of the distribution of psoriasis subtypes in different ethno-racial groups. Dermatol Online J. 2018;24(7):13030.","journal-title":"Dermatol Online J"},{"issue":"4","key":"981_CR123","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/1346-8138.17132","volume":"51","author":"M Tokuyama","year":"2024","unstructured":"Tokuyama M, Fan P, Wang G, Choe YB, Song HJ, Tsai D, et al. Epidemiological analysis of the patients with psoriasis in Asian countries and region using the same clinical case cards between 2020 and 2022. J Dermatol. 2024;51(4):567\u201383.","journal-title":"J Dermatol"},{"key":"981_CR124","unstructured":"WHO global report on trends in prevalence of tobacco use 2000\u20132030. Geneva: World Health Organization; 2024."},{"issue":"2","key":"981_CR125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1440-1843.2003.00464.x","volume":"8","author":"J Mackay","year":"2003","unstructured":"Mackay J, Amos A. Women and tobacco. Respirology. 2003;8(2):123\u201330.","journal-title":"Respirology"},{"issue":"1","key":"981_CR126","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50875-x","volume":"14","author":"K Yatsuzuka","year":"2024","unstructured":"Yatsuzuka K, Kawakami R, Niko Y, Tsuda T, Kameda K, Kohri N, et al. A fluorescence imaging technique suggests that sweat leakage in the epidermis contributes to the pathomechanism of palmoplantar pustulosis. Sci Rep. 2024;14(1): 378.","journal-title":"Sci Rep"},{"issue":"7","key":"981_CR127","volume":"19","author":"WH Kuan","year":"2022","unstructured":"Kuan WH, Chen YL, Liu CL. Excretion of Ni, Pb, Cu, As, and Hg in sweat under two sweating conditions. Int J Environ Res Public Health. 2022;19(7): 4323.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"981_CR128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3346\/jkms.2008.23.2.315","volume":"23","author":"YY Kim","year":"2008","unstructured":"Kim YY, Kim MY, Park YM, Kim HO, Koh CS, Lee HK. Evaluating the nickel content in metal alloys and the threshold for nickel-induced allergic contact dermatitis. J Korean Med Sci. 2008;23(2):315\u20139.","journal-title":"J Korean Med Sci"},{"issue":"6","key":"981_CR129","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12062232","volume":"12","author":"E Chai","year":"2023","unstructured":"Chai E, Tey HL, Lim ZV. Are there ethnic differences in hand eczema? A review. J Clin Med. 2023;12(6):2232.","journal-title":"J Clin Med"},{"issue":"10","key":"981_CR130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/1346-8138.16908","volume":"50","author":"Y Oshima","year":"2023","unstructured":"Oshima Y, Fujimoto T, Nomoto M, Fukui J, Ikoma A. Hyperhidrosis: a targeted literature review of the disease burden. J Dermatol. 2023;50(10):1227\u201336.","journal-title":"J Dermatol"},{"issue":"2","key":"981_CR131","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1067\/mva.2002.119507","volume":"35","author":"KM Ro","year":"2002","unstructured":"Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg. 2002;35(2):382\u20136.","journal-title":"J Vasc Surg"},{"issue":"2","key":"981_CR132","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1467-2494.2006.00302.x","volume":"28","author":"AV Rawlings","year":"2006","unstructured":"Rawlings AV. Ethnic skin types: are there differences in skin structure and function? Int J Cosm Sci. 2006;28(2):79\u201393.","journal-title":"Int J Cosm Sci."},{"key":"981_CR133","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jtherbio.2019.07.024","volume":"84","author":"A Best","year":"2019","unstructured":"Best A, Lieberman DE, Kamilar JM. Diversity and evolution of human eccrine sweat gland density. J Therm Biol. 2019;84:331\u20138.","journal-title":"J Therm Biol"},{"key":"981_CR134","volume":"252","author":"Y Qu","year":"2023","unstructured":"Qu Y, Ji S, Sun Q, Zhao F, Li Z, Zhang M, et al. Association of urinary nickel levels with diabetes and fasting blood glucose levels: a nationwide Chinese population-based study. Ecotoxicol Environ Saf. 2023;252: 114601.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"5","key":"981_CR135","first-page":"593","volume":"43","author":"HJLB Han","year":"2005","unstructured":"Han HJLB, Park CW, Lee CH, Kang YS. A study of nickel content in Korean foods. Korean J Dermatol. 2005;43(5):593\u20138.","journal-title":"Korean J Dermatol."},{"key":"981_CR136","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1590\/S0103-90162012000100008","volume":"69","author":"F Guerra","year":"2012","unstructured":"Guerra F, Trevizam AR, Muraoka T, Marcante NC, Canniatti-Brazaca SG. Heavy metals in vegetables and potential risk for human health. Sci Agric. 2012;69:54\u201360.","journal-title":"Sci Agric"},{"issue":"5","key":"981_CR137","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/DER.0000000000000220","volume":"27","author":"VA Deleo","year":"2016","unstructured":"Deleo VA, Alexis A, Warshaw EM, Sasseville D, Maibach HI, DeKoven J, et al. The association of race\/ethnicity and patch test results: North American Contact Dermatitis Group, 1998\u20132006. Dermatitis. 2016;27(5):288\u201392.","journal-title":"Dermatitis"},{"issue":"2","key":"981_CR138","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1067\/mjd.2002.120792","volume":"46","author":"VA Deleo","year":"2002","unstructured":"Deleo VA, Taylor SC, Belsito DV, Fowler JF Jr, Fransway AF, Maibach HI, et al. The effect of race and ethnicity on patch test results. J Am Acad Dermatol. 2002;46(2):S107\u201312.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"981_CR139","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00015550260132488","volume":"82","author":"B Kumar","year":"2002","unstructured":"Kumar B, Saraswat A, Kaur I. Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol. 2002;82(3):192\u20135.","journal-title":"Acta Derm Venereol"},{"key":"981_CR140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/0001555553112","volume":"53","author":"ML Psoriasis","year":"1973","unstructured":"Psoriasis ML. A study of the course and degree of severity, joint involvement, socio-medical conditions, general morbidity and influences of selection factors among previously hospitalized psoriatics. Acta Derm Venereol Suppl (Stockh). 1973;53:1\u2013125.","journal-title":"Acta Derm Venereol Suppl (Stockh)."},{"issue":"1","key":"981_CR141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000251595","volume":"148","author":"EM Farber","year":"1974","unstructured":"Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148(1):1\u201318.","journal-title":"Dermatologica"},{"issue":"1","key":"981_CR142","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2478\/anre-2019-0004","volume":"82","author":"S Kirchengast","year":"2019","unstructured":"Kirchengast S. Asymmetry patterns are associated with body size and somatic robustness among adult Kung San and Kavango people. Anthropol Rev. 2019;82(1):43\u201363.","journal-title":"Anthropol Rev"},{"issue":"2","key":"981_CR143","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40257-023-00833-0","volume":"25","author":"WC Chien","year":"2024","unstructured":"Chien WC, Tsai TF. Pressure and skin: a review of disease entities driven or influenced by mechanical pressure. Am J Clin Dermatol. 2024;25(2):261\u201380.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"981_CR144","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/DER.0000000000000961","volume":"34","author":"CY Hsieh","year":"2023","unstructured":"Hsieh CY, Tsai TF. Friction-aggravated skin disorders\u2014a review of mechanism and related diseases. Dermatitis. 2023;34(4):287\u201396.","journal-title":"Dermatitis"},{"issue":"7","key":"981_CR145","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1468-3083.2006.02065.x","volume":"21","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Yokozeki H, Tsuboi R. Koebner\u2019s phenomenon associated with palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2007;21(7):990\u20132.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"981_CR146","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMc1706162","volume":"377","author":"CM Costello","year":"2017","unstructured":"Costello CM, Pittelkow MR, Mangold AR. Acral melanoma and mechanical stress on the plantar surface of the foot. N Engl J Med. 2017;377(4):395\u20136.","journal-title":"N Engl J Med"},{"issue":"5","key":"981_CR147","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jfma.2023.10.015","volume":"123","author":"S-N Chen","year":"2024","unstructured":"Chen S-N, Lin M-H, Liao Y-H, Liau J-Y, Chu C-Y, Sheen Y-S. Anatomic mapping of acral melanocytic nevi and acral lentiginous melanomas among Taiwanese patients: a retrospective cohort study. J Formos Med Assoc. 2024;123(5):587\u201393.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"981_CR148","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00403-022-02324-4","volume":"315","author":"JE Ferguson","year":"2023","unstructured":"Ferguson JE, Seger EW, White J, McMichael A. Racial\/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review. Arch Dermatol Res. 2023;315(1):41\u201350.","journal-title":"Arch Dermatol Res"},{"key":"981_CR149","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jdin.2024.02.018","volume":"18","author":"MK Cho","year":"2025","unstructured":"Cho MK, Kim DH. Real-world experience of the efficacy and safety of guselkumab 100 mg in patients with palmoplantar pustulosis in Korea: a retrospective single-center study. JAAD Int. 2025;18:117\u20138.","journal-title":"JAAD Int"},{"key":"981_CR150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdin.2023.04.002","volume":"12","author":"JE Tarride","year":"2023","unstructured":"Tarride JE, Prajapati VH, Lynde C, Blackhouse G. The burden of palmoplantar pustulosis: a Canadian population-based study of inpatient care, emergency departments, and outpatient clinics. JAAD Int. 2023;12:151\u20139.","journal-title":"JAAD Int"},{"issue":"11","key":"981_CR151","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jdv.14386","volume":"31","author":"AA Navarini","year":"2017","unstructured":"Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Koks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31(11):1792\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"981_CR152","first-page":"642","volume":"58","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Feng J, Guo J, Zhuo L, Xu L, Liu L, et al. Epidemioloical characteristics and economic burden analysis of palmoplantar pustulosis in urban areas of China. Chin J Prev Med. 2024;58(5):642\u20138.","journal-title":"Chin J Prev Med"},{"issue":"5","key":"981_CR153","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1055\/s-0030-1252022","volume":"73","author":"I Schafer","year":"2011","unstructured":"Schafer I, Rustenbach SJ, Radtke M, Augustin J, Glaeske G, Augustin M. Epidemiology of psoriasis in Germany\u2014analysis of secondary health insurance data. Gesundheitswesen. 2011;73(5):308\u201313.","journal-title":"Gesundheitswesen"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-025-00981-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T15:45:57Z","timestamp":1763048757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-025-00981-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":153,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["981"],"URL":"https:\/\/doi.org\/10.1007\/s40257-025-00981-5","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Francis Li-Tien Hsu has no conflict of interest to disclose. Tsen-Fang Tsai has conducted clinical trials or received honoraria for serving as a consultant for Abbvie, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli-Lilly, Galderma, GSK, Janssen-Cilag, Leo Pharma, Merck Sharp and Dohme, Novartis International, Pfizer, PharmaEssentia, Sanofi, and UCB Pharma. Tsen-Fang Tsai is an Editorial Board member of the\n                      American Journal of Clinical Dermatology\n                      . Tsen-Fang Tsai was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"This article is a systematic review of previously published research and does not involve any new studies with human participants or animals conducted by the authors. As such, no ethical approval or informed consent was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"This is a systematic review article and does not present original research data. All data discussed in this article are derived from published studies and can be accessed from the respective original sources.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and Material Availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Material preparation, data collection, and analysis were performed by Francis Li-Tien Hsu. The first draft of the manuscript was written by Francis Li-Tien Hsu. Tsen-Fang Tsai is responsible for study conception, supervision and critical revision. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}